Mechanisms involved in the antiproliferative and proapoptotic effects of unsaponifiable fraction of extra virgin olive oil on HT-29 cancer cells

Nutrition and Cancer

Volumn 65, Issue 6, 2013, Pages 908-918

  Cárdeno, Ana ^a   Sánchez Hidalgo, Marina ^a   Cortes Delgado, Amparo ^b   Alarcón De La Lastra, Catalina ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b INSTITUTO DE LA GRASA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALKANOL; ALPHA TOCOPHEROL DERIVATIVE; CYCLOOXYGENASE 2; EXTRA VIRGIN OLIVE OIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIVE OIL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P53; SITOSTEROL DERIVATIVE; SQUALENE DERIVATIVE; STEROL DERIVATIVE; SULFORHODAMINE B; UNCLASSIFIED DRUG; UVAOL;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; CARCINOMA CELL; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; COLON ADENOCARCINOMA; COLON CANCER; CONCENTRATION (PARAMETERS); DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84882348871     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.806674     Document Type: Article

References (35)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al.: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 15, 2893-2917, 2010.
2. Watson AJ and Collins PD: Colon cancer: A civilization disorder. Dig Dis 29, 222-228, 2011.
3. Sofi F, Abbate R, Gensini GF, and Casini A: Accruing evidence on benefits of adherence to the Mediterranean diet on health: An updated systematic review and meta-analysis. Am J Clin Nutr 92, 1189-1196, 2010.
4. Escrich E, Moral R, and Solanas M: Olive oil, an essential component of the Mediterranean diet, and breast cancer. Public Health Nutr 14, 2323-2332, 2011.
5. Śanchez-Fidalgo S, Villegas I, Ćardeno A, Talero E, Śanchez-Hidalgo M, et al.: Extra-virgin olive oil-enriched diet modulates DSS-colitis-associated colon carcinogenesis in mice. Clin Nutr 29, 663-673, 2010.
6. Solanas M, Grau L, Moral R, Vela E, Escrich R, et al.: Dietary olive oil and corn oil differentially affect experimental breast cancer through distinct modulation of the p21Ras signaling and the proliferation-apoptosis balance. Carcinogenesis 31, 871-879, 2010.
7. Bermudez B,Lopez S, Ortega A, Varela LM, Pacheco YM, et al.: Oleic acid in olive oil: From a metabolic framework toward a clinical perspective. Curr Pharm Des 17, 831-843, 2011.
8. Escrich E, Solanas M, Moral R, and Escrich R: Modulatory effects and molecular mechanisms of olive oil and other dietary lipids in breast cancer. Curr Pharm Des 17, 813-830, 2011.
9. De la Lastra CA: An up-date of olive oil and bioactive constituents in health : Molecular mechanisms and clinical implications. Curr Pham Des 17, 752-753, 2011.
10. Menendez JA, Vazquez-Martin A, Oliveras-Ferraros C, Garcia-Villalba R, Carrasco-Pancorbo A, et al.: Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: Relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2. Int J Oncol 34, 43-51, 2009.
11. Fini L, Hotchkiss E, Fogliano V, Graziani G, RomanoM, et al.: Chemopreventive properties of pinoresinol-rich olive oil involve a selective activation of the ATM-p53 cascade in colon cancer cell lines. Carcinogenesis 29, 139-146, 2008.
12. Sotiroudis TG and Kyrtopoulos SA: Anticarcinogenic compounds of olive oil and related biomarkers. Eur J Nutr 47, 69-72, 2008.
13. Bhilwade HN, Tatewaki N, Nishida H, and Konishi T: Squalene as novel food factor. Curr Pharm Biotechnol 11, 875-880, 2010.
14. Mart́in R, Ibeas E, Carvalho-Tavares J, Herńandez M, Ruiz-Gutierrez V, et al.: Natural triterpenic diols promote apoptosis in astrocytoma cells through ROS-mediated mitochondrial depolarization and JNK activation. PLoS One 22, 59-75, 2009.
15. Mardones P and Rigotti A: Cellular mechanisms of vitamin E uptake: Relevance in alpha-tocopherol metabolism and potential implications for disease. J Nutr Biochem 15, 252-260, 2004.
16. Paquot C and Hautfenne A: Standard Method for the Analysis of Oils, Fats and Derivatives, 7th ed., rev. Blackwell, Oxford, England, 1992.
17. Commission Regulation (EEC) No 2568/91 of 11 July 1991 on the characteristics of olive oil and olive-residue oil and the relevant methods of analysis. Off J Eur Communities 248, 1-18, 1991.
18. Tocopherols and tocotrienols in vegetable oils and fats by HPLC. AOCS Ce 8-89, 1997.
19. Lanzon A, Albi T, Cert A, and Gracian J: The hydrocarbon fraction of Virgin Olive Oil and changes resulting from refining. J Am Oil Chem Soc 71, 285-291, 1994.
20. Lai ZC, Wei X, Shimizu T, Ramos E, Rohrbaugh M, et al.: Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 120, 675-685, 2005.
21. Smith TJ: Squalene: Potential chemopreventive agent. Expert Opin Investig Drugs 9, 1841-1848, 2000.
22. Baskar AA, Ignacimuthu S, Paulraj GM, and Al Numair KS: Chemopreventive potential of beta-Sitosterol in experimental colon cancer model-an in vitro and In vivo study. BMC Complement Altern Med 4, 10-24, 2010.
23. Ju J, Picinich SC,Yang Z, ZhaoY, Suh N, et al.:Cancer-preventive activities of tocopherols and tocotrienols. Carcinogenesis 31, 533-542, 2010.
24. Juan ME, Planas JM, Ruiz-Gutierrez V, Daniel H, andWenzel U: Antiproliferative and apoptosis-inducing effects of maslinic and oleanolic acids, two pentacyclic triterpenes from olives, on HT-29 colon cancer cells. Br J Nutr 100, 36-43, 2008.
25. Juan ME, Wenzel U, Daniel H, and Planas JM: Erythrodiol, a natural triterpenoid from olives, has antiproliferative and apoptotic activity in HT-29 human adenocarcinoma cells. Mol Nutr Food Res 52, 595-599, 2008.
26. Aggarwal BB and Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71, 1397-1421, 2006.
27. Alarćon de la Lastra C, Śanchez-Fidalgo S, Villegas I, and Motilva V: New pharmacological perspectives and therapeutic potential of PPAR-gamma agonists. Curr. Pharm. Des. 10, 3505-3524, 2004.
28. Wang J, Lv X, Shi J, Hu X, and Du Y: Troglitazone induced apoptosis via PPARγ activated POX-induced ROS formation in HT29 cells. Biomed Environ Sci 24, 391-399, 2011.
29. Cesario RM, Stone J, Yen WC, Bissonnette RP, and Lamph WW: Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer. Cancer Lett 240, 225-233, 2006.
30. Mustafa A and Kruger WD: Suppression of tumor formation by a cyclooxygenase-2 inhibitor and a peroxisome proliferator-activated receptor gamma agonist in an in vivo mouse model of spontaneous breast cancer. Clin Cancer Res 14, 4935-4942, 2008.
31. Atreya I, Atreya R, and Neurath MFJ: NF-kappaB in inflammatory bowel disease. Intern Med 263, 591-596, 2008.
32. Spychalski M, Dziki L, and Dziki A: Chemoprevention of colorectal cancer-a new target needed? Colorectal Dis 9, 397-401, 2007.
33. Subramaniya BR, Srinivasan G, Sadullah SS, DavisN, Subhadara LB, et al.: Apoptosis inducing effect of plumbagin on colonic cancer cells depends on expression of COX-2. PLoS One 6, 18695, 2011.
34. Fang JY and Richardson BC: TheMAPK signaling pathways and colorectal cancer. Lancet Oncol. 6, 322-327, 2005.
35. Tsuchiya T, Tsuno NH, Asakage M, Yamada J, Yoneyama S, et al.: Apoptosis induction by p38 MAPK inhibitor in human colon cancer cells. Hepatogastroenterology 55, 930-935, 2008.